Clinical Trial

A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male Subjects

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The study aims to evaluate the pharmacokinetics, mass balance recovery, metabolite profile and metabolite identification of \[14C\]HRS-1780 following an oral single dose in healthy adult male participants.
Trial Details
NCT Number NCT07557407
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Chronic Kidney Diseases
Enrollment 6 participants
Start Date 2026-05
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-29